Given the emerging role of endoscopic procedures in the treatment of obesity and rapid changes in endoscopic technologies and techniques, this review considers the current state of endoscopic management of obesity. Endoluminal interventions performed entirely through the GI tract by using flexible endoscopy offer the potential for an ambulatory weight loss procedure that may be safer and more cost- effective compared with current surgical approaches. Endoscopic techniques attempt to mimic the anatomic features of bariatric surgery. Accordingly, there are two main endoscopic weight loss modalities – restrictive and malabsorptive. Restrictive procedures act to decrease gastric volume by space-occupying prosthesis and/or by suturing or stapling devices, while malabsorptive procedures tend to create malabsorption by preventing food contact with the duodenum and proximal jejunum. The former include intragastric balloon treatment, endoluminal vertical gastroplasty, transoral gastroplasty and transoral endoscopic restrictive implant system, while the latter include duodenojejunal bypass sleeve. Gastroduodenojejunal bypass sleeve is a combination of both procedures. Except for intragastric balloon, all mentioned procedures are rather new, tested on a small number of human subjects, with a high rate of success, but with limited knowledge on safety and long-term efficacy. The role of gastric electrical stimulation and intragastric injections of botulinum toxin in obesity treatment is also considered as is the role of minimally invasive bariatric endoscopic interventions.

Keywords:
Obesity treatment, Endoluminal interventions, Endoscopic techniques, Restrictive procedures, Malabsorptive procedures, Intragastric balloon, Botulinum toxin
1.
Hankey CR: Weight-loss interventions in the treatment of obesity. Nutr Soc 2010;69:34–38.
2.
Robinson MK: Surgical treatment of obesity – weighing the facts. N Engl J Med 2009;361:520–521.
3.
Morino M, Toppino M, Forestieri P, et al: Mortality after bariatric surgery: analysis of 13871 morbidly obese patients from a national registry. Ann Surg 2007;246:1002–1007.
4.
Coté GA, Edmundowicz SA: Emerging technology: endoluminal treatment of obesity. Gastrointest Endosc 2009;70:991–999.
5.
Kumar N, Thompson CC: Endoscopic solutions for weight loss. Curr Opin Gastroenterol 2011;27:407–411.
6.
Thompson CC: Endoscopic therapy of obesity: a new paradigm in bariatric care. Gastrointest Endosc 2010;72:505–507.
7.
Ryou M, Ryan MC, Thompson CC: Current status of endoluminal bariatric procedures for primary and revision indications. Gastrointest Endosc Clin N Am 2011;21:315–333.
8.
Melissas J, Mouzas J, Fills D, et al: The intragastric balloon – smoothing the path to bariatric surgery. Obes Surg 2006;16:897–902.
9.
Spyropolos C, Katsakoulis E, Mead N, et al: Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Relat Dis 2007;3:78–83.
10.
Genco A, Bruni T, Doldi SB, et al: BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg 2005;15:1161–1164.
11.
Lopez-Nava G, Rubio MA, Prados S, et al: BioEnterics intragastric balloon (BIB). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011;21:5–9.
12.
Stimac D, Majanovic SK, Turk T, Kezele B, Licul V, Orlic ZC: Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg 2011;21:551–555.
13.
Dastis NS, François E, Deviere J, Hittelet A, Ilah Mehdi A, Barea M, Dumonceau JM: Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009;41:575–580.
14.
Kadirkamanathan SS, Evans DF, Gong F, Yazaki E, Scott M, Swain CP: Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointest Endosc 1996;44:133–143.
15.
Rothstein RI, Filipi CJ: Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am 2003;13:89–101.
16.
Schwartz MP, Wellink H, Gooszen HG, et al: Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut 2007;56:20–28.
17.
Fogel R, De Fogel J, Bonilla Y, et al: Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008;68:51–58.
18.
Thompson CC, Brethauer SA, Chand B, et al: Transoral gastric volume reduction as an intervention for weight management (TRIM) multicenter feasibility study: a report of early outcomes. Gastroenterology 2009;136: A-384.
19.
Devière J, Ojeda Valdes G, Cuevas Herrera L, et al: Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc 2008;22:589–598.
20.
Moreno C, Closset J, Dugardeyn S, et al: Transoral gastroplasty is safe, feasible and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008;40:406–413.
21.
Chiellini C, Iaconelli A, Familiari P, Riccioni ME, Castagneto M, Nanni G, Costamagna G, Mingrone G: Study of the effects of transoral gastroplasty on insulin sensitivity and secretion in obese subjects. Nutr Metab Cardiovasc Dis 2010;20:202–207.
22.
de Jong K, Mathus-Vliegen EMH, Veldhuyzen EAML, et al: Short-term safety and efficacy of the Trans-Oral Endoscopic Restrictive Implant System for the treatment of obesity. Gastrointest Endosc 2010;72:497–504.
23.
Verlaan T, de Jong K, Mathus-Vliegen EM, et al: Evaluation of the safety and efficacy results of the Trans-Oral Endoscopic Restrictive System (TERIS) for the treatment of obesity at six months (Mo270); presented at Digestive Disease Week, Chicago, May 2011.
24.
Ellsmere JC, Thompson CC, Brugge WR, Chuttani R, Desilets DJ, Rattner DW, Tarnoff ME, Kaplan LM: Endoscopic interventions for weight loss surgery. Obesity 2009;17:929–933.
25.
Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al: First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008;4:55–59.
26.
Tarnoff M, Rodriguez L, Escalona A, et al: Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009;23:650–656.
27.
De Moura EG, Martins BC, Lopes GS, et al: Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 2011;14:183–189.
28.
Sandler BJ, Rumbaut R, Swain CP, et al: Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc 2011;25:3028–3033.
29.
Gui D, Mingrone G, Valenza V, et al: Effect of botulinum toxin antral injection on gastric emptying and weight rediction in obese patients: a pilot study. Aliment Pharmacol Ther 2006;23:675–680.
30.
Mittermair R, Keller C, Geibel J: Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg 2007;17:732–736.
31.
Foschi D, Corsi F, lazzaroni M, et al: Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes (Lond) 2007;31:707–712.
32.
Garcia-Compean D, Garza HM: Intragastric injection of botulinum toxin for the treatment of obesity. Where are we? World J Gastroenterol 2008;14:1805–1809.
33.
Xu X, Pasricha PJ, Chen JD: Feasibility of gastric electrical stimulation by use of endoscopically placed electrodes. Gastrointest Endosc 2007;66:981–986.
34.
Sallam HS, Chen JD, Pasricha PJ: Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. Gastrointest Endosc 2008;68:754–759.
35.
Sanmiguel CP, Conklin JL, Cunneen SA, et al: Gastric electrical stimulation with the TANTALUS system in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol 2009;3:964–970.
36.
Camilleri M, Toouli J, Herrera MF, et al: Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery 2008;143:723–731.
37.
Fernandez-Esparrach G, Cordova H, Bordas JM, et al: Endoscopic management of the complications of the bariatric surgery. Experience of more than 400 interventions. Gastroenterol Hepatol 2011;34:131–136.
38.
Schauer P, Chand B, Brethauer S: New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc 2007;21:347–356.
39.
Hawes R: ASGE/SAGES Working Group on Natural Orifice Transluminal Endoscopic Surgery. Gastrointest Endosc 2006;63:199–203.
40.
Tsesmeli N, Coumaros D: The future of bariatrics: endoscopy, endoluminal surgery, and natural orifice transluminal endoscopic surgery. Endoscopy 2010;42:155–162.
41.
Ho KY, Phee LS, Kencana AP, et al: Ingestible wireless capsule for treatment of obesity (Mo1348); presented at Digestive Disease Week, Chicago, May 2011.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.